Research Areas of Special Interest:

  • Minimally invasive surgery techniques
  • Quality outcomes in cancer surgeries
  • Physiology of circulating gastrointestinal regulatory peptides
  • Radioimmunoassay of peptides in pathophysiological conditions
  • Role of cholecystokinin in the control of growth and regulation of the pancreas
  • Pathophysiology of an endocrine tumor-peptic ulcer model
  • Oncogene expression and amplification in carcinoid tumors
  • Molecular and physiological regulation of small bowel absorption
  • Molecular profiling of gastrointestinal malignancies
  • Immunotherapy of gastrointestinal malignancies

Research and Clinical Trial Cooperative Groups:

  • 1999-2001 Invited Participant/Co-Investigator, American College of Surgeons Oncology Group
    • Lymph node mapping and sentinel lymph node biopsy for stage I, II, III colon
      Cancer
  • Current Co-Founder, International Consortium of Research (INCORE) of the Theodor-Billroth-Academy (TBA), Munich, Germany
  • Current Member, United States Military Cancer Institute, Bethesda, MD

Research Grant Funding:

  • 1988-1989 Amelioration of traumatic pancreatitis by CCK antagonist.
    • OHSE research award-Yale University. $10,000, PI – AJ Bilchik M.D.
  • 1989-1990 Bacterial and specific contribution to the mortality of post traumatic pancreatitis in a guinea pig model.
    • OHSE research award-Yale University. $9,500, PI – AJ Bilchik M.D
  • 1990-1991 Oncogene expression in mastomys carcinoid tumors.
    • OHSE research fund award-Yale University. $10,000, PI – AJ Bilchik M.D
  • 1991-1997 Surgery and intestinal absorption.
    • NIH DK39870-05. (Co-investigator) $600,000, PI – MJ Zinner
  • 1997 Early diagnosis and treatment of pancreatic cancer.
    • SPORE institutional grant (Collaborator)
  • 1998 Molecular Detection of Colon Cancer with a Multiple Marker PCR Assay.
    • Rod Fasone Fund $10,000
  • 1998-1999 Rogavin-Davidow Foundation $75,000
  • 1998-1999 Polyvalent Vaccine: Phase III Trial in Stage IV Melanoma
    • NIH/NCI 5 P-01 CA29605-18 $878,746, PI – DL Morton M.D.
  • 1998-1999 New Approaches to Surgical Oncology
    NIH/NCI 5 P01 CA 29605-18 $2,218,374, PI – DL Morton M.D.
  • 1999 Rod Fasone Fund $15,000
  • 1999-2000 Rogavin-Davidow Foundation $75,000
  • 1999-2000 Surgery, Immunology and Immunology of Human Cancer
    • NIH/NCI 5 P01 CA12582-28 $3,810,835, PI – DL Morton, M.D.
  • 1999-2000 Unrestricted research grant – Rita Medical Incorporated $50,000
  • 2000 Rod Fasone Fund $10,000
  • 2000-2003 Ultrastaging of Early Colon Cancer Using Lymphatic Mapping and Sentinel Node Analysis $150,000, PI – AJ Bilchik M.D. Ph.D.
  • 2000-2006 Ultrastaging of Early Colon Cancer Using Lymphatic Mapping and Sentinel Node Analysis
    • NIH/NCI 1 R01 CA90848-01 $2,631,076, PI – AJ Bilchik M.D. Ph.D.
  • 2000-2005 Lymph node mapping and sentinel lymph node biopsy for stage I, II, III colon
    cancer. American College of Surgeons Oncology Group Grant (submitted)
    Collaborator / Co-Investigator – AJ Bilchik M.D. Ph.D.
  • 2000-2001 Carbohydrate Antigens As Targets for Vaccine Immunotherapy in Colon Cancer NIH/NCI K08 Grant (submitted), PI – AJ Bilchik M.D. Ph.D.
  • 2000-2001 Carbohydrate Antigens As Targets for Vaccine Immunotherapy in Colon Cancer American Cancer Society Beginning Investigators Grant (submitted), PI – AJ Bilchik M.D. Ph.D.
  • 2000-2001 Rogavin-Davidow Foundation $75,000
  • 2001 Polyvalent Vaccine: Phase III Trial in Stage IV Colon Cancer, PI – AJ Bilchik, M.D., Ph.D.
  • 2001 Rod Fasone Fund $15,000
  • 2001 George Hoag Foundation $35,000
  • 2001-2002 Rogavin-Davidow Foundation $75,000
  • 2002 SPORE in Pancreas Cancer, Co-Investigator – AJ Bilchik M.D. Ph.D., PI – T Adrian, Ph.D.
  • 2002 William Randolph Hearst Foundation $500,000
  • 2002-2003 Davidow Charitable Fund $75,000
  • 2003-2004 Davidow Charitable Fund $75,000
  • 2004-2005 Davidow Charitable Fund $75,000
  • 2004-2006 Davidow Charitable Fund $75,000
  • 2009-2012 William Randolph Hearst Foundation $150,000
  • 2008-2013 Ultrastaging of Early Colon Cancer. NIH/NCI 2RO1 CA90848-05A2 $2,638,184.
    • PI – AJ Bilchik M.D.Ph.D. FUNDED
  • 2010-2014 Molecular Profiling of Stage II Colon Cancer: US Military Cancer Institute Clinical Trials Group GI-02 $3,555,125 PI AJ Bilchik M.D.Ph.D. Submitted DOD